Nitrosamines are known to be carcinogenic and have the potential to be intermediates in organic synthesis. Due to their potent genotoxicity, nitrosamines have been a serious cause for concern. it has now become a requirement to accurately quantitate this group of compounds in pharmaceuticals during drug development and manufacturing. Below you will find the latest resources to help you improve your LC-MS quantitation of nitrosamines. If you looking to improve your nitrosamine analysis please do not hesitate to contact us.
|HPLC||Gemini||3 µm C18 150 x 4.6 mm||Ph. Eur. method for N-Nitrosamines in active substances|
|HPLC||Kinetex||2.6 µm Biphenyl 150 x 3 mm
2.6 µm Biphenyl 150 x 4.6 mm
|Sartan drugs, metformin and ranitidine|
|HPLC||Kinetex||2.6 µm F5 50 x 2.1 mm||Rapid analysis of genotoxic nitrosamines|
|GC||Zebron||ZB-624plus 30 m x 0.25 mm x 1.40 µm||Analysis of NDMA and NDEA in sartan drugs|